Covishield

Chhattisgarh to receive 3.23 lakh coronavirus vaccine doses

11:17 pm January 12, 2021

Raipur: The Chhattisgarh government on Tuesday said the state will get 3.23 lakh doses of Covishield,the COVID-19 vaccine manufactured by the Pune-based Serum Institute of India (SII), as part of the first batch of consignment for the upcoming vaccination drive. The consignment is likely to reach Raipur on Wednesday, but so far no official confirmation […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech set to dispatch first consignment of Covaxin

2:55 pm January 12, 2021

Hyderabad : Bharat Biotech, which has received Emergency Use Authorisation approval from the Drug Controller General of India for its COVID-19 vaccine Covaxin,is set to dispatch it from the Rajiv Gandhi International Airport here on Tuesday evening, a senior official of the Airports cargo division said. ”Today we have received the first consignment of vaccines […]

Read More

16 lakh frontline workers in Karnataka to get COVID vaccine in first phase: CM

9:13 pm January 11, 2021

Bengaluru: About 16 lakh frontline workers in Karnataka will be administered COVID-19 vaccine in the first phase starting from January 16, Chief Minister B S Yeddyurappa said on Monday. A second dose will be given 28 days after the first jab,he told reporters here after attending Prime Minister Narendra Modi’s virtual meet with Chief Ministers […]

Read More

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT Secy

9:47 pm January 5, 2021

New Delhi: All Indian vaccines being developed against the coronavirus will have to be stored at 2-8 degrees Celsius as the logistics have been worked out while considering temperature as a factor, Department of Biotechnology Secretary Renu Swarup said on Tuesday. Swarup said Bharat Biotech’s COVID-19 vaccine Covaxin and Oxford AstraZeneca’s Covishield have robustly undergone immunoassay lab tests. “(For) all our […]

Read More

CDSCO panel recommends grant of permission for restricted emergency use of Oxford COVID-19 vaccine

10:55 pm January 1, 2021

New Delhi: An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford COVID-19 vaccine Covishield in India, subject to certain regulatory provisions, official sources said. As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the […]

Read More